Sofocure™-L (Manufactured by Emcure®)
Brand Name: Sofocure™-L (Manufactured by Emcure®)
Composition: Ledipasvir 90 mg & Sofosbuvir 400 mg Tablets
Product Description
Medical Info
Sofocure™-L is a powerful, fixed-dose combination antiviral medication containing Ledipasvir (90 mg) and Sofosbuvir (400 mg), designed for a 28-tablet treatment regimen. It is primarily indicated for the treatment of chronic Hepatitis C virus (HCV) genotype 1, 4, 5, or 6 infections. By combining two distinct mechanisms—Ledipasvir as an NS5A inhibitor and Sofosbuvir as a nucleotide analog NS5B polymerase inhibitor—it directly targets and disrupts viral replication. This highly effective synergy helps clear the virus from the body, offering a high cure rate and supporting long-term liver health under proper medical supervision.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
